Screener
Ironwood Pharmaceuticals IRWD Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
The source filing: Ironwood Pharmaceuticals’s 10-K, filed February 26, 2026. Open the filing →
- Filed
- Feb 26, 2026, 4:09 PM EST
- Fiscal year
- FY2025
- Accession
- 0001104659-26-020489
FAQ
- What is Ironwood Pharmaceuticals's free cash flow?
- Ironwood Pharmaceuticals (IRWD) reported free cash flow of $74.58M in Q4 2025.
- How has Ironwood Pharmaceuticals's free cash flow changed year-over-year?
- Ironwood Pharmaceuticals's free cash flow increased by 390.2% year-over-year, from $15.21M to $74.58M.
- What is the long-term trend for Ironwood Pharmaceuticals's free cash flow?
- Over 3 years (2021 to 2024), Ironwood Pharmaceuticals's free cash flow has grown at a -26.5% compound annual growth rate (CAGR), from $260.66M to $103.41M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Ironwood Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude